Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2 Aminoethanethiol
2. 2-aminoethanethiol
3. 35s-labeled Cysteamine
4. Becaptan
5. Beta Mercaptoethylamine
6. Beta-mercaptoethylamine
7. Bitartrate, Cysteamine
8. Cystagon
9. Cysteamine
10. Cysteamine Bitartrate
11. Cysteamine Dihydrochloride
12. Cysteamine Hydrobromide
13. Cysteamine Maleate (1:1)
14. Cysteamine Tartrate
15. Cysteamine Tartrate (1:1)
16. Cysteamine Tosylate
17. Cysteamine, 35s Labeled
18. Cysteamine, 35s-labeled
19. Cysteinamine
20. Dihydrochloride, Cysteamine
21. Hydrobromide, Cysteamine
22. Hydrochloride, Cysteamine
23. Mercamine
24. Mercaptamine
25. Mercaptoethylamine
26. Tartrate, Cysteamine
27. Tosylate, Cysteamine
1. 156-57-0
2. 2-aminoethanethiol Hydrochloride
3. Cysteamine Hcl
4. 2-mercaptoethylamine Hydrochloride
5. Mercaptamine Hydrochloride
6. Bekaptan
7. Cysteaminium Chloride
8. Ethanethiol, 2-amino-, Hydrochloride
9. Mercaptoethylamine Hydrochloride
10. Cysteamine (hydrochloride)
11. 2-thioethylamine Hydrochloride
12. Cysteamine Hydrochloride [usan]
13. 2-aminoethane-1-thiol Hydrochloride
14. 2-aminoethanethiol;hydrochloride
15. Beta-mercaptoethylamine Hydrochloride
16. Mfcd00012904
17. Nsc-758692
18. 2-mercaptoethylammonium Chloride
19. Ci-9148
20. If1b771svb
21. Thioethanolamine Hydrochloride
22. 2-aminoethylmercaptan Hydrochloride
23. Nsc-21116
24. Nsc-25116
25. Ncgc00094090-01
26. 2-mercaptoethylamine Hcl
27. Dsstox_cid_25779
28. Dsstox_rid_81121
29. Dsstox_gsid_45779
30. Merkamin Hydrochloride
31. Cysteamine Hydrochloride (usan)
32. Mercamine Hydrochloride
33. Cysteamine Chlorohydrate
34. Usaf Ee-3
35. Cas-156-57-0
36. Cysteaminhydrochlorid
37. Cysteaminhydrochlorid [german]
38. Ccris 3926
39. Eta-mercaptoethylamine Hydrochloride
40. 1-aminoethane-2-thiol Hydrochloride
41. Einecs 205-858-1
42. Nsc 21116
43. Unii-if1b771svb
44. 1-amino-2-mercaptoethane Hydrochloride
45. Ci 9148
46. Ethylamine, 2-mercapto-, Hydrochloride
47. Cysteamine-hcl
48. Ai3-26089
49. Ccris 3619
50. Beta-mercaptoaethylamin Chlorhydrat [german]
51. A-889
52. Beta-mercaptoaethylamin Chlorhydrat
53. Cystaran (tn)
54. Decarboxycystine Hcl
55. Cym-h.hcl
56. Cystadrops
57. Cysteamine Hydrochoride
58. 2-aminoethanethiol-hcl
59. Cysteamine, Hydrochloride
60. Spectrum2_001667
61. Spectrum3_000992
62. Spectrum4_001120
63. Spectrum5_001422
64. (beta)-mea Hydrochloride
65. Ec 205-858-1
66. Schembl51598
67. Kbiogr_001600
68. Mls000028734
69. Cysteamine Hcl [inci]
70. Decarboxycysteine Hydrochloride
71. Spectrum1504226
72. 2-aminoethanthiol Hydrochloride
73. Spbio_001853
74. Mercaptamine; Mea Hydrochloride
75. Chembl1256137
76. Dtxsid8045779
77. 2-amino-ethanethiol Hydrochloride
78. 2-aminoethanethiol, Hydrochloride
79. B-mercaptoethylamine Hydrochloride
80. Kbio3_001903
81. 2-mercaptoethanamine Hydrochloride
82. A-mercaptoethylamine Hydrochloride
83. Cysteamine Hydrochloride, Bioxtra
84. Hms1922h05
85. Pharmakon1600-01504226
86. Bcp15033
87. Hydrochloric Acid 2-aminoethanethiol
88. Tox21_111245
89. Tox21_500749
90. Ac-301
91. Ccg-39094
92. Cysteamine Hydrochloride [mi]
93. Nsc758692
94. S4206
95. Akos007929948
96. Tox21_111245_1
97. Lp00749
98. 2-aminoethanethiol Hydrochloride (1:1)
99. Cysteamine Hydrochloride [vandf]
100. Ncgc00015691-06
101. Ncgc00094090-02
102. Ncgc00094090-03
103. Ncgc00094090-04
104. Ncgc00261434-01
105. As-12111
106. Hy-77591
107. Mercaptamine Hydrochloride [mart.]
108. Smr000059101
109. 2-aminoethanethiol Chloride;cysteamine Hcl
110. Cysteamine Hydrochloride, >=97.0% (rt)
111. Mercaptamine Hydrochloride [who-dd]
112. Db-043323
113. A0296
114. Cysteamine Hydrochloride, Analytical Standard
115. Eu-0100749
116. Ft-0611242
117. Sw219210-1
118. Cysteamine Hydrochloride [orange Book]
119. Cysteamine Hydrochloride, >=98% (titration)
120. Ethanethiol, 2-amino-, Hydrochloride (1:1)
121. A16474
122. C-9520
123. D03635
124. D70222
125. M 6500
126. A809757
127. Sr-01000075546-1
128. Q27280697
129. Cysteamine Hydrochloride, Vetec(tm) Reagent Grade, 98%
130. F2191-0299
131. Cysteamine Hydrochloride, Pharmagrade, Manufactured Under Appropriate Controls For Use As Raw Material In Pharma Or Biopharmaceutical Production.
132. Cysteamine Hydrochloride, Pharmagrade, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production
| Molecular Weight | 113.61 g/mol |
|---|---|
| Molecular Formula | C2H8ClNS |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 113.0065981 g/mol |
| Monoisotopic Mass | 113.0065981 g/mol |
| Topological Polar Surface Area | 27 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 10 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Cystaran |
| PubMed Health | Cysteamine (Into the eye) |
| Drug Classes | Ophthalmologic Agent |
| Drug Label | CYSTARAN is a sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride, equivalent to 4.4 mg/mL of cysteamine (0.44%) as the active ingredient. Cysteamine is a cystine-depleting agent which lowers the cystine content of cells in p... |
| Active Ingredient | Cysteamine hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.44% base |
| Market Status | Prescription |
| Company | Sigma Tau |
| 2 of 2 | |
|---|---|
| Drug Name | Cystaran |
| PubMed Health | Cysteamine (Into the eye) |
| Drug Classes | Ophthalmologic Agent |
| Drug Label | CYSTARAN is a sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride, equivalent to 4.4 mg/mL of cysteamine (0.44%) as the active ingredient. Cysteamine is a cystine-depleting agent which lowers the cystine content of cells in p... |
| Active Ingredient | Cysteamine hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | eq 0.44% base |
| Market Status | Prescription |
| Company | Sigma Tau |
Cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.
Cystine Depleting Agents
Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS. (See all compounds classified as Cystine Depleting Agents.)
S01XA21
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Parenteral
Solubilizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Cysteamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cysteamine Hydrochloride, including repackagers and relabelers. The FDA regulates Cysteamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cysteamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cysteamine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cysteamine Hydrochloride supplier is an individual or a company that provides Cysteamine Hydrochloride active pharmaceutical ingredient (API) or Cysteamine Hydrochloride finished formulations upon request. The Cysteamine Hydrochloride suppliers may include Cysteamine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Cysteamine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cysteamine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Cysteamine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Cysteamine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Cysteamine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cysteamine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Cysteamine Hydrochloride USDMF includes data on Cysteamine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cysteamine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cysteamine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cysteamine Hydrochloride Drug Master File in Japan (Cysteamine Hydrochloride JDMF) empowers Cysteamine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cysteamine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Cysteamine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cysteamine Hydrochloride suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cysteamine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cysteamine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cysteamine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cysteamine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cysteamine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cysteamine Hydrochloride suppliers with NDC on PharmaCompass.
Cysteamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cysteamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cysteamine Hydrochloride GMP manufacturer or Cysteamine Hydrochloride GMP API supplier for your needs.
A Cysteamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Cysteamine Hydrochloride's compliance with Cysteamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Cysteamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Cysteamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cysteamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Cysteamine Hydrochloride EP), Cysteamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cysteamine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
